Taiwan · Delayed Price · Currency is TWD Medigen Vaccine Biologics Statistics
Total Valuation
TPEX:6547 has a market cap or net worth of TWD 16.93 billion. The enterprise value is 15.99 billion.
| Market Cap | 16.93B |
| Enterprise Value | 15.99B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6547 has 328.75 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 328.75M |
| Shares Outstanding | 328.75M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 2.56% |
| Float | 257.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 55.98 |
| PS Ratio | 29.50 |
| PB Ratio | 4.76 |
| P/TBV Ratio | 4.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.37, with a Debt / Equity ratio of 0.31.
| Current Ratio | 22.37 |
| Quick Ratio | 17.43 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.07 |
| Interest Coverage | -20.58 |
Financial Efficiency
Return on equity (ROE) is -4.62% and return on invested capital (ROIC) is -2.62%.
| Return on Equity (ROE) | -4.62% |
| Return on Assets (ROA) | -2.54% |
| Return on Invested Capital (ROIC) | -2.62% |
| Return on Capital Employed (ROCE) | -3.91% |
| Weighted Average Cost of Capital (WACC) | 3.72% |
| Revenue Per Employee | 5.57M |
| Profits Per Employee | -1.62M |
| Employee Count | 103 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.41 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.07% in the last 52 weeks. The beta is -0.06, so TPEX:6547's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | +29.07% |
| 50-Day Moving Average | 47.33 |
| 200-Day Moving Average | 43.26 |
| Relative Strength Index (RSI) | 59.30 |
| Average Volume (20 Days) | 2,876,531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6547 had revenue of TWD 573.85 million and -166.77 million in losses. Loss per share was -0.53.
| Revenue | 573.85M |
| Gross Profit | 361.55M |
| Operating Income | -181.12M |
| Pretax Income | -166.77M |
| Net Income | -166.77M |
| EBITDA | -53.89M |
| EBIT | -181.12M |
| Loss Per Share | -0.53 |
Balance Sheet
The company has 2.04 billion in cash and 1.10 billion in debt, with a net cash position of 936.80 million or 2.85 per share.
| Cash & Cash Equivalents | 2.04B |
| Total Debt | 1.10B |
| Net Cash | 936.80M |
| Net Cash Per Share | 2.85 |
| Equity (Book Value) | 3.56B |
| Book Value Per Share | 11.14 |
| Working Capital | 2.67B |
Cash Flow
In the last 12 months, operating cash flow was -55.34 million and capital expenditures -162.21 million, giving a free cash flow of -217.55 million.
| Operating Cash Flow | -55.34M |
| Capital Expenditures | -162.21M |
| Depreciation & Amortization | 121.81M |
| Net Borrowing | 745.83M |
| Free Cash Flow | -217.55M |
| FCF Per Share | -0.66 |
Margins
Gross margin is 63.00%, with operating and profit margins of -31.56% and -29.06%.
| Gross Margin | 63.00% |
| Operating Margin | -31.56% |
| Pretax Margin | -29.06% |
| Profit Margin | -29.06% |
| EBITDA Margin | -9.39% |
| EBIT Margin | -31.56% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6547 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -0.99% |
| FCF Yield | -1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.
| Last Split Date | Aug 3, 2022 |
| Split Type | Forward |
| Split Ratio | 1.48280574 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |